Inventor
LIN NAN-HORNG
US45 patents
⚠️ This page may combine multiple inventors who share the name “LIN NAN-HORNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
25 patentsUS5278176AJan 11, 1994
Nicotine derivatives that enhance cognitive function
ABBOTT LAB137 citations98
US5948793ASep 7, 1999
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
ABBOTT LAB77 citations96
US5629325AMay 13, 1997
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
ABBOTT LAB106 citations96
US6437138B1Aug 20, 2002
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
ABBOTT LAB54 citations95
US5914328AJun 22, 1999
Heterocyclic ether compounds useful in controlling neurotransmitter release
ABBOTT LAB67 citations95
US5472958ADec 5, 1995
2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
ABBOTT LAB55 citations93
US6127386AOct 3, 2000
3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
ABBOTT LAB47 citations92
US5733912AMar 31, 1998
7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
ABBOTT LAB35 citations92
US5409946AApr 25, 1995
Isoxazole, isothiazole and pyrazole compounds that enhance cognitive function
ABBOTT LAB50 citations91
US6656958B2Dec 2, 2003
Substituted pyridine compounds useful for controlling chemical synaptic transmission
ABBOTT LAB13 citations84
US7456169B2Nov 25, 2008
Heterocyclic kinase inhibitors
ABBOTT LAB9 citations83
US6133253AOct 17, 2000
3-Pyridyl enantiomers and their use as analgesics
ABBOTT LAB12 citations72
US5508418AApr 16, 1996
Intermediates for the preparation of enantiomerically-pure-3-methyl-5-(1-C1-C3-alkyl)-2-pyrrolidinyl)isoxazole
ABBOTT LAB1 citations63
US7323570B2Jan 29, 2008
Farnesyltransferase inhibitors
ABBOTT LAB2 citations62
US7211595B2May 1, 2007
Farnesyltransferase inhibitors
ABBOTT LAB5 citations62
US7056925B2Jun 6, 2006
Urea kinase inhibitors
ABBOTT LAB2 citations62
US6797825B2Sep 28, 2004
Protein kinase inhibitors
ABBOTT LAB3 citations62
US6001849ADec 14, 1999
Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission
ABBOTT LAB6 citations62
US7956185B2Jun 7, 2011
Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases
ABBOTT LAB5 citations61
US6403575B1Jun 11, 2002
3-Pyridyl enantiomers and their use as analgesics
ABBOTT LAB3 citations61
US5424444AJun 13, 1995
Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(S)-pyrrolidinyl) isoxazoles
ABBOTT LAB2 citations54
US5559242ASep 24, 1996
Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(S)-pyrrolidinyl) isoxazoles
ABBOTT LAB0 citations52
US5516912AMay 14, 1996
Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(s)-pyrrolidinyl)isoxazoles
ABBOTT LAB0 citations52
US7320986B2Jan 22, 2008
Fused tri and tetra-cyclic pyrazole kinase inhibitors
ABBOTT LAB0 citations40
US7163939B2Jan 16, 2007
Macrocyclic kinase inhibitors
ABBOTT LAB0 citations39
MILES INC
5 patentsUS5126275AJun 30, 1992
Analytical method using tetrazolium salt indicators having a reflectance plateau
MILES INC27 citations90
US5300637AApr 5, 1994
2-benzothiazolyl tetrazolium salt indicators
MILES INC12 citations71
USRE34919EApr 25, 1995
Dithiophenylpyrrole derivative monomers for preparing semi-conducting polymers
MILES INC2 citations63
US5068355ANov 26, 1991
Semi-conducting oligomers and method relating thereto
MILES INC2 citations63
US5021586AJun 4, 1991
Dithiophenylpyrrole derivative monomers for preparing semi-conducting polymers
MILES INC1 citations52
CHO PHARMA INC
5 patentsUS10538592B2Jan 21, 2020
Antibodies, binding fragments, and methods of use
CHO PHARMA INC2 citations70
US11135306B2Oct 5, 2021
Antibody-drug conjugates
CHO PHARMA INC2 citations65
US10407673B2Sep 10, 2019
Methods for glycoprotein remodeling using endoglycosidase mutants
CHO PHARMA INC1 citations57
US11628225B2Apr 18, 2023
Antibody-drug conjugates
CHO PHARMA INC0 citations55
US10000747B2Jun 19, 2018
Endoglycosidase mutants for glycoprotein remodeling and methods of using it
CHO PHARMA INC0 citations47
BARBIER LINDSAY BURNS
4 patentsUS8653068B2Feb 18, 2014
Filamin A binding anti-inflammatory and analgesic
BARBIER LINDSAY BURNS15 citations81
US8580808B2Nov 12, 2013
Filamin A-binding anti-inflammatory analgesic
BARBIER LINDSAY BURNS6 citations81
US8580809B2Nov 12, 2013
Filamin A-binding anti-inflammatory analgesic
BARBIER LINDSAY BURNS7 citations81
US9340558B2May 17, 2016
Filamin a binding anti-inflammatory and analgesic
BARBIER LINDSAY BURNS1 citations49
BIOMEA FUSION INC
2 patentsUS12018032B2Jun 25, 2024
Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction
BIOMEA FUSION INC0 citations55
US11945785B2Apr 2, 2024
Pyrazine compounds as inhibitors of FLT3
BIOMEA FUSION INC0 citations46